Artemis Medicare Q1 FY27 Revenue Up 12.7%, PAT Surges 48.3%

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorRiya Kapoor|Published at:
Artemis Medicare Q1 FY27 Revenue Up 12.7%, PAT Surges 48.3%

Artemis Medicare Services reported a strong Q1 FY27 with revenue growing 12.7% to ₹287.32 crore and net profit jumping 48.3% to ₹31.44 crore. The company is expanding capacity with new facilities in Raipur and South Delhi, backed by a ₹700 crore fundraising plan.

Artemis Medicare Services Q1 FY27 Results

Artemis Medicare Services reported strong Q1 FY27 results, with consolidated revenue rising 12.7% year-on-year to ₹287.32 crore. Net profit surged by 48.3% to ₹31.44 crore.

Reader Takeaway: Strong profit growth driven by operational efficiency and capacity expansion plans.

What just happened

Artemis Medicare Services announced its financial results for the first quarter of FY27. The company achieved consolidated revenue of ₹287.32 crore, marking a 12.7% increase compared to the same period last year. Consolidated EBITDA stood at ₹56.44 crore, with an expanded margin of 21.5%, up from 19.0% in Q1 FY26. The net profit after tax (PAT) saw a significant jump of 48.3%, reaching ₹31.44 crore.

Why this matters

The robust growth in revenue and particularly the substantial increase in net profit indicate improved operational efficiency and profitability. The expansion of EBITDA margins highlights effective cost management and pricing power. These results suggest the company is on a strong growth trajectory, with its strategic expansion initiatives expected to drive future performance.

The backstory

Artemis Medicare Services operates a chain of hospitals. The Gurgaon facility has been a consistent performer. The company has been focusing on expanding its healthcare network to cater to a wider patient base and strengthen its market presence. Recent operationalisation of the Raipur facility and planning for the South Delhi expansion are key strategic moves.

What changes now

With the commencement of operations at the Raipur facility and the planned expansion in South Delhi, Artemis Medicare is set to significantly increase its bed capacity in the coming years. The approved fundraising of ₹700 crore will provide the necessary capital for these ambitious growth plans. This signals a phase of aggressive expansion and potential market share gains.

Risks to watch

While the company's financial performance is strong, a notable point is the decline in 'Other Income,' which the company attributes to the utilization of funds for expansion projects. Investors should monitor how this impacts overall profitability and whether the expansion projects yield the expected returns.

Peer comparison

While specific peer data is not provided in the filing, Artemis Medicare's growth in revenue and profit in the hospital sector is generally positive. Other healthcare providers are also focusing on expansion and improving operational metrics like bed occupancy and Average Revenue Per Occupied Bed (ARPOB).

Context metrics (time-bound)

  • Consolidated Revenue (Q1 FY27): ₹287.32 crore (up 12.7% YoY)
  • Consolidated PAT (Q1 FY27): ₹31.44 crore (up 48.3% YoY)
  • Consolidated EBITDA Margin (Q1 FY27): 21.5% (up 256 bps YoY)
  • Gurgaon Bed Occupancy (Q1 FY27): 65.7% (up 443 bps YoY)

What to track next

Investors should closely watch the ramp-up and financial performance of the newly operational Raipur facility. Progress on the planned South Delhi hospital, including timelines and approvals, will be crucial. The efficient deployment of the ₹700 crore capital raise and its impact on overall debt and profitability will also be key monitoring points.

Disclaimer: This article is published for informational purposes only. This is not a buy sell recommendation.